Skip to main content
Clinical Trials/ACTRN12620001161910
ACTRN12620001161910
Not yet recruiting
未知

Evaluation of the accuracy of a Novel Medtronic Extended Life Continuous Glucose Sensor in people with type 1 diabetes

St Vincent's Hospital Melbourne0 sites40 target enrollmentNovember 5, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 diabetes
Sponsor
St Vincent's Hospital Melbourne
Enrollment
40
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 5, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St Vincent's Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Participants will be considered for inclusion in the study if they meet all the following criteria:
  • 1\. Participant is over 18 years of age at time of screening.
  • 2\. A clinical diagnosis of Type\-1 Diabetes, as determined by the Investigator.
  • 3\. Participant is using insulin to treat his/her Diabetes.
  • 4\. Currently using a sensor or has experience with sensor use.
  • 5\. Preference will be given to subjects who have a history of hypoglycaemia.
  • 6\.Participant is willing to comply with all requirements associated with the protocol.

Exclusion Criteria

  • Participants will be excluded from the study for any of the following reasons:
  • 1\. Participant has a positive pregnancy screening test.
  • 2\. Any known allergies to glucocorticoid steroids
  • 3\. Participant is female and plans to become pregnant during the study.
  • 4\. Participant is unable to tolerate tape adhesive in the region of sensor placement.
  • 5\. Participant has any unresolved adverse skin condition in the region of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection).
  • 6\. Recent (\< 3months) episode of severe hypoglycaemia or Diabetic ketoacidosis.
  • 7\. Known major life\-threatening disease or psychiatric illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials